Gang Zeng, Ph.D.

A Short Biography:

Dr. Zeng joined UCLA from the National Cancer Institute in 2002. He is a tumor immunologist with an interest in translational research. His research has been supported by peer-reviewed grants from the National Cancer Institute, Department of Defense, American Cancer Society, as well as a few private foundations. He is an associated member of the NCI Early Detection Research Network (EDRN).

Work Titles
UCLA Associate Professor, Urology Member, Tumor Immunology Program at the Jonsson Comprehensive Cancer Center (JCCC)

Contact Information:

Work Phone Number:

(310) 794-7635

Office Address:

650 Charles Young Drive
Los Angeles, CA 90095

Work Address:

12-256 Factor
Campus - 173818
Los angeles, CA 90095


A selected list of publications:

Pantuck AJ, Zeng G, Belldegrun AS, Figlin RA   Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway, Clinical cancer research, ; 9(13): 4641-52.
Liu Yanan, Zeng Gang   Cancer and innate immune system interactions: translational potentials for cancer immunotherapy Journal of immunotherapy (Hagerstown, Md. : 1997), 2012; 35(4): 299-308.
Liu Yanan, Tian Xiaoli, Leitner Wolfgang W, Aldridge Michael E, Zheng Junying, Yu Zhiya, Restifo Nicholas P, Weiss Richard, Scheiblhofer Sandra, Xie Chong, Sun Ren, Cheng Genhong, Zeng Gang   Polymeric structure and host Toll-like receptor 4 dictate immunogenicity of NY-ESO-1 antigen in vivo The Journal of biological chemistry, 2011; 286(43): 37077-84.
Meng Zhaoting, Wang Yadong, Zhang Guanzhong, Ke Yuehua, Yan Yanfeng, Wu Liangliang, Huang Qianrong, Zeng Gang, Wang Yu, Ying Han, Jiao Shunchang   Identification of an HLA-DPB1*0501 restricted Melan-A/MART-1 epitope recognized by CD4+ T lymphocytes: prevalence for immunotherapy in Asian populations Journal of immunotherapy (Hagerstown, Md. : 1997), 2011; 34(7): 525-34.
Xie Chong, Kim Hyun J, Haw Jonathan G, Kalbasi Anusha, Gardner Brian K, Li Gang, Rao Jianyu, Chia David, Liong Monty, Punzalan Rubio R, Marks Leonard S, Pantuck Allan J, de la Taille Alexandre, Wang Guomin, Mukouyama Hideki, Zeng Gang   A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases Journal of translational medicine, 2011; 9(3): 43.
Baratelli Felicita, Takedatsu Hiroko, Hazra Saswati, Peebles Katherine, Luo Jie, Kurimoto Pam S, Zeng Gang, Batra Raj K, Sharma Sherven, Dubinett Steven M, Lee Jay M   Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer Journal of translational medicine, 2008; 6(2): 38.
Shvarts Oleg, Janzen Nicolette, Lam John S, Leppert John T, Caliliw Randy, Figlin Robert A, Belldegrun Arie S, Zeng Gang   RENCA/carbonic anhydrase-IX: a murine model of a carbonic anhydrase-IX-expressing renal cell carcinoma Urology, 2006; 68(5): 1132-8.
Zeng Gang, Aldridge Michael E, Tian Xiaoli, Seiler Daniel, Zhang Xiaolong, Jin Yusheng, Rao Jianyu, Li Weidong, Chen Dequan, Langford Marlyn P, Duggan Chris, Belldegrun Arie S, Dubinett Steven M   Dendritic cell surface calreticulin is a receptor for NY-ESO-1: direct interactions between tumor-associated antigen and the innate immune system Journal of immunology (Baltimore, Md. : 1950), 2006; 177(6): 3582-9.
Lam John S, Seligson David B, Yu Hong, Li Ai, Eeva Mervi, Pantuck Allan J, Zeng Gang, Horvath Steve, Belldegrun Arie S   Flap endonuclease 1 is overexpressed in prostate cancer and is associated with a high Gleason score BJU international, 2006; 98(2): 445-51.
Baratelli Felicita, Lin Ying, Zhu Li, Yang Seok-Chul, Heuzé-Vourc'h Nathalie, Zeng Gang, Reckamp Karen, Dohadwala Mariam, Sharma Sherven, Dubinett Steven M   Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells Journal of immunology (Baltimore, Md. : 1950), 2005; 175(3): 1483-90.
Zeng Gang, Aldridge Michael E, Wang Yu, Pantuck Allan J, Wang Allen Y, Liu Yue-xiang, Han Yan, Yuan Yan-hua, Robbins Paul F, Dubinett Steven M, deKernion Jean B, Belldegrun Arie S   Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarker International journal of cancer. Journal international du cancer, 2005; 114(2): 268-73.
Liu Gentao, Yu John S, Zeng Gang, Yin Dong, Xie Dong, Black Keith L, Ying Han   AIM-2: a novel tumor antigen is expressed and presented by human glioma cells Journal of immunotherapy (Hagerstown, Md. : 1997), 2004; 27(3): 220-6.
Liu Gentao, Ying Han, Zeng Gang, Wheeler Christopher J, Black Keith L, Yu John S   HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells Cancer research, 2004; 64(14): 4980-6.
Mukouyama Hideki, Janzen Nicolette K, Hernandez Jose M, Lam John S, Caliliw Randy, Wang Allen Y, Figlin Robert A, Belldegrun Arie S, Zeng Gang   Generation of kidney cancer-specific antitumor immune responses using peripheral blood monocytes transduced with a recombinant adenovirus encoding carbonic anhydrase 9 Clinical cancer research : an official journal of the American Association for Cancer Research, 2004; 10(4): 1421-9.
Pantuck Allan J, Zeng Gang, Belldegrun Arie S, Figlin Robert A   Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway Clinical cancer research : an official journal of the American Association for Cancer Research, 2003; 9(13): 4641-52.

Does this profile need updating? Contact Us